Skip to main content

Validation and comparison of tumor-associated trypsin inhibitor (TATI) immunoassays.

Janeiro E, Guimarães J, Stenman UH, Catarino M, Itkonen O

Publication: Clin Chim Acta (2012) • Vol 413 • Page 1244-8PMID: 22507084View on PubMed

Purpose

The purpose of this paper was to determine the effects of patient age and gender, fasting prior to collection, collection tube type, storage, freeze-thaw cycling, and quantification platform on levels of tumor-associated trypsin inhibitor (TATI) in serum.

Conclusion

Patient age significantly affected serum TATI levels in specimens from both men and women, and levels were higher in 18-30 year old women than men in the same age range. Fasting prior to blood draw and collection tube type did not affect TATI levels, and levels were not different between lithium-heparin plasma and serum. The authors report declines in serum TATI concentrations after storage at 4, -20 or -80 degrees C or after 4 freeze-thaw cycles compared to initial levels measured in fresh specimens. The median measured TATI concentrations differed significantly between radioimmunoassay (RIA), time-resolved immunofluorometric assay (TR-IFMA) and enzyme-linked immunosorbent assay (ELISA), and the intra-assay coefficient of variance (CV) and recovery of TATI in spiked plasma depended on technology platform.

Studies (1)

Purpose

The purpose of this study was to determine the effects of patient age and gender, fasting prior to collection, collection tube type, storage, freeze-thaw cycling, and quantification platform on TATI concentrations in serum and the effects of collecting lithium-heparin plasma instead of serum on TATI levels. To determine the effect of long-term storage, TATI levels in 152 specimens stored at -70 degrees C for 9-11 years were compared to levels in 15 fresh specimens. For the freeze-thaw experiment no details of storage duration or thaw temperature or duration were included.

Summary of Findings

TATI levels were significantly lower in specimens from women aged 31-50 years than those from 18-30 year old women (p=0.0115). In both men and women, TATI was higher serum from individuals over 70 years old than in serum from 51-70 year old patients (p=0.0005 and p=0.0001, respectively). Serum TATI levels were higher in specimens from 18-30 year old women than those from men of the same age (p<0.0001), but no other gender differences were observed. Fasting prior to blood draw, collecting lithium-heparin plasma rather than serum, and serum tube type had no effects on TATI concentrations. The authors report that when serum was stored for 4 weeks at 4 or 20 degrees C, TATI concentrations decreased from initial levels by 15.9% and 19.9%, respectively, but the authors did not note any differences observed at other timepoints. Similarly, the authors report that after 8 weeks at -80 degrees C, TATI concentrations decreased by 19% from initial levels, but they do not discuss other timepoints. Further, the authors report a 19.2% decline in TATI levels after serum was subjected to 4 freeze-thaw cycles at -20 degrees C. Specimens stored for 9-11 years at -70 degrees C had a mean TATI concentration that was 18% lower than the mean level in fresh specimens. The median TATI concentrations were 11.0, 13.5, and 16.0 ug/L using the RIA, IFMA and ELISA, respectively (p<0.0001, all). The intra-assay CVs using ELISA and IFMA were 7.1% and 9.7%, respectively, at 9.5 ug/L and 9.1% and 3.5%, respectively, at 18.8 ug/L. Further, recovery of TATI from spiked serum was less than 87.7-98.7% using IFMA, but 100-117% using ELISA.

  • Biospecimens

    FluidPlasma
    FluidSerum
    FluidBlood
  • Preservation Types

    None (Fresh)Frozen
  • Diagnoses

    Normal
  • Platforms

    ProteinELISA
    ProteinRadioimmunoassay
    ProteinImmunoassay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionPatient age
    18-30 years
    31-50 years
    51-70 years
    >70 years
    PreaquisitionPatient gender
    Female
    Male
    Biospecimen AcquisitionTime of biospecimen collection
    After Finish breakfast
    Before eating
    Biospecimen AcquisitionType of collection container/solution
    Clotting catalyzator tube
    Glass tube
    Lithium-heparin tube
    SST II advance tube
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Serum
    Biospecimen PreservationType of fixation/preservation
    Frozen
    None (fresh)
    StorageStorage duration
    0 days
    1 week
    2 weeks
    4 weeks
    8 weeks
    9-11 years
    StorageStorage temperature
    -20 degrees C
    -70 degrees C
    -80 degrees C
    4 degrees C
    Immunoassay SpecificTechnology platform
    ELISA
    RIA
    TR-IFMA